Oral PresentationsWorkshop 4. New insights from inflammation and immunologyWS04.2 Improvement in inflammatory biomarkers in patients (pts) with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation treated with lumacaftor (LUM) and ivacaftor (IVA)
Workshop 4. New insights from inflammation and immunology
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.